Corvus Pharmaceuticals, Inc. Fair Value, Assets, Level 1 to Level 2 Transfers, Amount
Corvus Pharmaceuticals, Inc. (CRVS) had Fair Value, Assets, Level 1 to Level 2 Transfers, Amount of $0 as of 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount · last filed 2022-11-03
- 2022-09-30: Fair Value, Assets, Level 1 to Level 2 Transfers, Amount $0.00.
- 2022-06-30: Fair Value, Assets, Level 1 to Level 2 Transfers, Amount $0.00.
- 2022-03-31: Fair Value, Assets, Level 1 to Level 2 Transfers, Amount $0.00.
- 2021-12-31: Fair Value, Assets, Level 1 to Level 2 Transfers, Amount $0.00.
| Period end | Fair Value, Assets, Level 1 to Level 2 Transfers, Amount |
|---|---|
| 2022-09-30 | $0.00 10-Q · filed 2022-11-03 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-08 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-05 |
| 2021-12-31 | $0.00 10-K · filed 2022-03-10 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-01 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-02 |
| 2021-03-31 | $0.00 10-Q · filed 2021-04-29 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-10 |
| 2020-09-30 | $0.00 10-Q · filed 2020-10-29 |
| 2020-06-30 | $0.00 10-Q · filed 2020-07-30 |
| 2020-03-31 | $0.00 10-Q · filed 2020-04-30 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-25 |
| 2019-09-30 | $0.00 10-Q · filed 2019-10-29 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-01 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-09 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-09 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-01 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-02 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-03 |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-02 |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-03 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-04 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-03 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-04 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Apnimed, Inc. (APMD) | United States | $0.899B |